Literature DB >> 907325

Netilmicin pharmacokinetics after single intravenous doses to elderly male patients.

P G Welling, A Baumueller, C C Lau, P O Madsen.   

Abstract

The pharmacokinetics of the new aminoglycoside antibiotic netilmicin were examined after single intravenous injections at two different dose levels to elderly male patients. The durg obeyed two-compartment model kinetics in serum, and elimination was monoexponential from 1 to 2 h after dosing. Netilmicin levels in serum were above minimum inhibitory concentration values for most susceptible organisms for up to 8 h after dosing in normal individuals and for at least 12 h in uremic patients. Urine levels of netilmicin were uniformly above minimum inhibitory concentration values throughout 24 h after dosing. Netilmicin distribution characteristics were largely independent of both dose level and renal function. Netilmicin elimination kinetics were independent of dose level but were markedly influenced by renal function. Relationships are described between netilmicin elimination and renal function indicators, which provide a basis for dosage adjustment in individuals with renal function impairment.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 907325      PMCID: PMC429913          DOI: 10.1128/AAC.12.3.328

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Pharmacokinetics of cefazolin in normal and uremic subjects.

Authors:  P G Welling; W A Craig; A L Gordon; C M Kunin
Journal:  Clin Pharmacol Ther       Date:  1974-04       Impact factor: 6.875

2.  Serum creatinine and drug half-lives.

Authors:  J Kampmann; J M Hansen; K Siersbaek-Nielsen; M Kristensen
Journal:  JAMA       Date:  1973-01-08       Impact factor: 56.272

3.  Effects of change in elimination on varous parameters of the two-compartment open model.

Authors:  W J Jusko; M Gibaldi
Journal:  J Pharm Sci       Date:  1972-08       Impact factor: 3.534

4.  Concept of a volume of distribution and possible errors in evaluation of this parameter.

Authors:  S Riegelman; J Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

5.  Blood levels of drug at the equilibrium state after multiple dosing.

Authors:  J G Wagner; J I Northam; C D Alway; O S Carpenter
Journal:  Nature       Date:  1965-09-18       Impact factor: 49.962

6.  Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic.

Authors:  G H Miller; G Arcieri; M J Weinstein; J A Waitz
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

7.  Comparative nephrotoxicities of netilmicin and gentamicin in rats.

Authors:  F C Luft; M N Yum; S A Kleit
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

8.  Treatment with sisomicin of complicated urinary tract infections in patients with varying degrees of renal function impairment, pharmacokinetics and dosage adjustment.

Authors:  A Mosegaard; P G Welling; F L Tse; P Madsen
Journal:  Infection       Date:  1975       Impact factor: 3.553

9.  Bactericidal efficacy of Sch 20569 and amikacin against gentamicin-sensitive and -resistant organisms.

Authors:  J J Rahal; M S Simberkoff; K Kagan; N H Moldover
Journal:  Antimicrob Agents Chemother       Date:  1976-04       Impact factor: 5.191

10.  Antimicrobial activity in vitro of netilmicin and comparison with sisomicin, gentamicin, and tobramycin.

Authors:  B R Meyers; S Z Hirschman
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

View more
  19 in total

Review 1.  Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.

Authors:  K Mörike; M Schwab; U Klotz
Journal:  Drugs Aging       Date:  1997-04       Impact factor: 3.923

Review 2.  Clinical pharmacokinetics of aminoglycoside antibiotics.

Authors:  J C Pechere; R Dugal
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447

3.  Pharmacokinetics of netilmicin in renal insufficiency and haemodialysis.

Authors:  J C Pechere; R Dugal; M M Pechere
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

4.  Comparison of netilmicin and gentamicin pharmacokinetics in humans.

Authors:  M Chung; R Costello; S Symchowicz
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

Review 5.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

6.  Clinical efficacy and toxicity of netilmicin in the treatment of gram-negative infections.

Authors:  F J Buckwold; A R Ronald; B Lank; L Thompson; L Fox; G K Harding
Journal:  Can Med Assoc J       Date:  1979-01-20       Impact factor: 8.262

Review 7.  Nonparametric meta-analysis of published data on kidney-function dependence of pharmacokinetic parameters for the aminoglycoside netilmicin.

Authors:  F Keller; K Erdmann; M Giehl; P Buettner
Journal:  Clin Pharmacokinet       Date:  1993-07       Impact factor: 6.447

8.  Isepamicin disposition in subjects with various degrees of renal function.

Authors:  C E Halstenson; J S Kelloway; M B Affrime; C C Lin; M A Teal; B E Shapiro; W M Awni
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

9.  Single-dose treatment with netilmicin for different clinical forms of urinary tract infections.

Authors:  V Prát; M Horcicková; M Hatala; K Matousovic; M Liska; J Hnátek; Z Milotová
Journal:  Infection       Date:  1984 Mar-Apr       Impact factor: 3.553

10.  Comparison of netilmicin and amikacin in treatment of complicated urinary tract infections.

Authors:  S Maigaard; N Frimodt-Möller; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.